Health Care & Life Sciences » Pharmaceuticals | Karolinska Development AB

Karolinska Development AB

Karolinska Development AB
Stock Exchange OTC Publication Venue
EPS
SEK0.49
Market Cap
SEK244.51 M
Shares Outstanding
62.92 M
Public Float
50.03 M

Profile

Address
Tomtebodavägen 23A
Solna AB 171 65
Sweden
Employees -
Website http://www.karolinskadevelopment.com
Updated 07/08/2019
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments.

Financials

View All
Created with Highcharts 5.0.14Karolinska Development ABNet Income. Fiscal year is January-December. All values SEK Thousands.157 315157 315375 815375 8151 054 6731 054 673216 832216 832179 595179 59530 51030 5102013201420152016201720180250k500k750k1 000k1 250k
Created with Highcharts 5.0.14Karolinska Development ABSales/Revenue. Fiscal year is January-December. All values SEK Thousands.4 9484 9485 6675 6675 4025 4026 3576 35752 59052 590102 653102 653201320142015201620172018025k50k75k100k125k

Hans Lennart Rudolf Wigzell
Chairman
Y Y Tse
Director